TORONTO - Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company, has announced the completion of a private placement funding round on February 12, 2025, raising approximately ...

Edesa Biotech (EDSA) announced that it has sold, in a private placement, an aggregate of 834 newly designated Series B-1 convertible preferred ...

Financing led by Velan Capital with participation from new and existing healthcare-focused institutional investors and insidersCapital raise to ...

President Marcos leads the campaign kickoff of the Alyansa Para sa Bagong Pilipinas Senate slate in his hometown ...